Northwest Financial Advisors Royalty Pharma PLC Transaction History
Northwest Financial Advisors
- $145 Billion
- Q2 2024
A detailed history of Northwest Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northwest Financial Advisors holds 126 shares of RPRX stock, worth $3,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126
Previous 120
5.0%
Holding current value
$3,496
Previous $3.64 Million
8.84%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
396Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.22 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$639 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$454 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$332 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...